Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Homology Medicines, Inc. | Chief Medical Officer | Common Stock | 7.5K | $4.24K | $0.57 | Aug 3, 2023 | Direct |
Neurogene Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 75K | Jan 16, 2024 | Direct | ||
Homology Medicines, Inc. | Chief Medical Officer | Restricted Stock Units | 0 | $1.15 | Aug 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NGNE | Neurogene Inc. | Jan 16, 2024 | 1 | $0 | 4 | Jan 18, 2024 | Chief Medical Officer |
NGNE | Neurogene Inc. | Jan 16, 2024 | 0 | $0 | 3 | Jan 18, 2024 | Chief Medical Officer |
FIXX | Homology Medicines, Inc. | Aug 3, 2023 | 9 | -$2.58K | 4 | Aug 7, 2023 | Chief Medical Officer |
FIXX | Homology Medicines, Inc. | Aug 2, 2023 | 3 | -$130 | 4 | Aug 4, 2023 | Chief Medical Officer |
FIXX | Homology Medicines, Inc. | Mar 7, 2023 | 0 | $0 | 3 | Mar 16, 2023 | Chief Medical Officer |